GRI Bio Inc - GRI Total Company Value-to-Revenue Ratio

Public company logo of GRI Bio (GRI)

GRI Bio, Inc. (GRI) specializes in the development of immunological drugs. This EV/Sales multiple chart illustrates the business value-to-revenue trend, where the value 0.00 characterizes this level. The company minimizes costs by outsourcing production and testing to third-party contractors. Reputable scientists oversee a transparent pipeline, ensuring efficient cash allocation. A lean research staff is retained through long-term options, expanding only to support new trial phases.

GRI Bio Corporation - GRI EV/Sales Multiple (period 11/23/2025 - 11/20/2026)

GRI (gribio.com): analytical breakdowns and indicator data

Fundamental valuation:GRI Bio, Inc. GRI
Original product of GRI Bio, Inc.

This indicator determines the market value of the business, accounting for net debt relative to sales volume, which allows for the identification of consolidation zones and the avoidance of value traps. By analyzing the enterprise value-to-revenue chart, an investor assesses the capitalization efficiency of the robotic cell platforms of GRI Bio, Inc. (GRI), where laboratory automation should convert into sustainable growth of operating metrics and a fair market valuation.

Competitor analysis for GRI Bio, Inc.

ARGX - EV/Sales Multiple|BNTX: EV/Sales Multiple|ABVX (Abivax SA) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio ADMA Corp|Enterprise Value-to-Revenue Multiple Protagonist Therapeutics PTGX|Company Value to Revenue IMVT (Immunovant Therapeutics)|Total Company Value-to-Revenue Ratio kiniksa.com|Enterprise Value-to-Revenue Ratio Grifols Biemat GRFS|Enterprise Value-to-Revenue Coefficient ADPT (Adaptive Biotechnologies Corporation)|celldex.com - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Aurinia Pharma AUPH|biocryst.com (BCRX) - Enterprise Value-to-Revenue Ratio|Vera Therapeutics, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple ABCL|Tourmaline Corp - Company Value to Revenue Ratio|EV/Sales Multiple PGEN (precigen.com)|Enterprise Value-to-Sales Ratio pharming.com|NKTR - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple Upstream Bio Corp|ZBIO: EV/Sales Multiple|Company Value to Revenue Immunome, Inc.|Company Value to Revenue GOSS|KALV: Business Value to Revenue|EV/Sales Multiple SEPN|Company Value to Revenue Pieris Pharmaceuticals, Inc. PVLA|EV/Sales Multiple SVRA (Savara Inc)|EV/Sales Multiple Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - EV/Sales Multiple|Astria Therapeutics - Enterprise Value-to-Revenue Coefficient|ENGN: EV/Sales Multiple|RAPT - Total Company Value-to-Revenue Ratio|Company Value to Revenue JBIO|Aclaris (ACRS) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple KYTX|Company Value to Revenue Tiziana Life Sciences TLSA|EV/Sales Multiple CABA (cabalettabio.com)|Enterprise Value-to-Revenue Coefficient VTYX (Ventyx Bio)|Theratechnologies, Inc - EV/Sales Multiple|AVTX (Avalo Therapeutics Inc.) - Company Value to Revenue Ratio|eledon.com (ELDN) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Ratio AGEN|CLYM (climbbio.com) - EV/Sales Multiple|EV/Sales Multiple zurabio.com|Enterprise Value-to-Revenue Ratio aTyr (ATYR)|ADAG - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio ImageneBio Inc IMA|EV/Sales Multiple Shattuck Labs, Inc. STTK|EQ - Enterprise Value-to-Revenue Ratio|connectbiopharm.com (CNTB) - Company Value to Revenue|IMUX (Immunic) - Company Value to Revenue|Atara Biotherapeutics, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio InflaRx|Company Value to Revenue x4pharma.com (XFOR)|EV/Sales Multiple ACET|Company Value to Revenue Celularity Corp CELU|INmune Bio Inc - Company Value to Revenue|BRNS (Barinthus Bio) - Enterprise Value to Sales Volume|KZR - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Enterprise Value-to-Revenue Ratio|ENLV - Total Company Value-to-Revenue Ratio|QTTB (Q32 Bio) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple GeoVax Labs Inc GOVX|Enterprise Value-to-Revenue Ratio Edesa Biotech (EDSA)|Company Value to Revenue iBio IBIO|Carisma Therapeutics Inc - Company Value to Revenue|XTLB - Company Value to Revenue|BOLT - Enterprise Value-to-Revenue Ratio|Business Value to Revenue HCWB (hcwbiologics.com)|APVO: EV/Sales Multiple|aimimmuno.com (AIM) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio aditxt.com|EV/Sales Multiple XORTX Therapeutics Inc|Enterprise Value-to-Revenue Ratio Vyome Therapeutics (HIND)|REVB - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Indaptus Therapeutics, Inc. INDP|EV/Sales Multiple scinai.com SCNI|CalciMedica Inc - EV/Sales Multiple|AFMD - EV/Sales Multiple|ALLK: EV/Sales Multiple|Enterprise Value to Sales Volume HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - EV/Sales Multiple|ITOS: Business Value to Revenue|Company Value to Revenue OCEA (Ocean Biomedical)|TCBP: Enterprise Value to Sales Volume|Enterprise Value-to-Revenue Ratio Third Harmonic Bio Inc THRD